BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rittiphairoj T, Mir TA, Li T, Virgili G. Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 2020;11:CD005656. [PMID: 33206392 DOI: 10.1002/14651858.CD005656.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin Y, Ren X, Chen D. Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis. Front Pharmacol 2022;13:824790. [PMID: 35273502 DOI: 10.3389/fphar.2022.824790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uemura A, Fruttiger M, D'Amore PA, De Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res 2021;:100954. [PMID: 33640465 DOI: 10.1016/j.preteyeres.2021.100954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Arrigo A, Bandello F. Molecular Features of Classic Retinal Drugs, Retinal Therapeutic Targets and Emerging Treatments. Pharmaceutics 2021;13:1102. [PMID: 34371793 DOI: 10.3390/pharmaceutics13071102] [Reference Citation Analysis]
4 Li X, Zhang J, He R, Su X, Li Z, Xie X. Effect of Chinese herbal compounds on ocular fundus signs and vision in conventional treated-persons with non-proliferative diabetic retinopathy: A systematic review and meta-analysis. Front Endocrinol 2022;13:977971. [DOI: 10.3389/fendo.2022.977971] [Reference Citation Analysis]
5 Berdugo M, Delaunay K, Lebon C, Naud MC, Radet L, Zennaro L, Picard E, Daruich A, Beltrand J, Kermorvant-Duchemin E, Polak M, Crisanti P, Behar-Cohen FF. Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model. Pharmaceutics 2021;13:1095. [PMID: 34371786 DOI: 10.3390/pharmaceutics13071095] [Reference Citation Analysis]
6 Wirkkala J, Kubin AM, Ohtonen P, Yliselä J, Siik T, Hautala N. Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study. BMC Ophthalmol 2022;22:258. [PMID: 35681133 DOI: 10.1186/s12886-022-02482-z] [Reference Citation Analysis]
7 Xiaodong L, Xuejun X, Panos G. The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials. Journal of Ophthalmology 2022;2022:1-11. [DOI: 10.1155/2022/4007002] [Reference Citation Analysis]